NR1D2 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-02-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
=== Bill Adler === Bill Adler (Trevor White) is the global head of FICC (Fixed Income, Currencies and Commodities) at Pierpoint, and is based out of the New York headquarters. Adler is a ruthless pragmatist fiercely devoted to the firm; he is also a longtime friend of Eric, who initially hired him, but as his senior, he is shown to feel entitled to Eric's loyalty and support. Adler first appears in the series 1 finale to vet new grads on the RIF day. He makes Harper a deal to reinstate Eric after she got him fired for his verbal abuse in the workplace. In series 2, Eric visits Adler in New York following the loss of Felim Bichan as a client and confronts him over reduced compensation for his team and the rumored consolidation of the London and New York desks. Adler rebuffs Eric, citing his underperformance, and sidelines him in a non-trading role. DVD later goes to Adler to report client Nicole Craig's sexual assault of new hire Venetia Berens, but Adler tells him to bury the case. When Harper and Eric go to Adler proposing a leaner London office and threaten to publicize Pierpoint's culture of suppression, Adler accepts their terms, consolidating CPS and FX and allowing DVD to be dismissed. In series 3, Adler supports Eric’s promotion to partner but orders him to fire a trader to demonstrate authority, leading Eric to dismiss Kenny Kilbane. Adler intervenes directly on the trading floor during the Lumi IPO to reassure investors.
== Indications == D-dimer testing is of clinical use when there is a suspicion of deep venous thrombosis (DVTl), pulmonary embolism (PE) or disseminated intravascular coagulation (DIC). For DVT and PE, there are possible various scoring systems that are used to determine the a priori clinical probability of these diseases; the best-known is the Wells score.
For instance, lichenologists long recognized species pairs where one species is fertile (has apothecia) and a very similar one is sterile but has abundant vegetative propagules such as soredia or isidia. Classical "species-pairs"—for example, fertile Parmelia saxatilis versus sorediate P. sulcata—have proven to be single species exhibiting alternative reproductive modes. DNA data have therefore prompted many merges, where differences were superficial, and still more splits, where hidden lineages emerged. Lichenologists now rely on integrative taxonomy and modern delimitation tools to resolve species limits. Current practice combines genetic, morphological, and ecological evidence when defining species. Lücking, Leavitt, and David Leslie Hawksworth (2021) proposed a "Lichen Unified Species Concept" that weighs three evidence lines: Lineage (genetic divergence), Phenotype (morphology/chemistry), and Reproduction (isolation)—the LPR framework. A robust species is one that forms a well-supported clade, shows consistent phenotypic differences from relatives, and exhibits some reproductive barrier. Complete evidence is rare; the aim is concordance among whatever data are available. The authors also framed taxonomy in terms of errors: false positives (over-splitting) and false negatives (over-lumping). Morphology alone risks false positives; a single gene alone risks false negatives.
The fas receptor (First apoptosis signal) – (also known as Apo-1 or CD95) is a transmembrane protein of the TNF family which binds the Fas ligand (FasL). The interaction between Fas and FasL results in the formation of the death-inducing signaling complex (DISC), which contains the FADD, caspase-8 and caspase-10. In some types of cells (type I), processed caspase-8 directly activates other members of the caspase family, and triggers the execution of apoptosis of the cell. In other types of cells (type II), the Fas-DISC starts a feedback loop that spirals into increasing release of proapoptotic factors from mitochondria and the amplified activation of caspase-8.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Sources: en.wikipedia.org
=== Elderly === Additional caution is required in the elderly, as they are more sensitive to the pharmacological effects of benzodiazepines, metabolise them more slowly, and are more prone to adverse effects, including drowsiness, amnesia (especially anterograde amnesia), ataxia, hangover effects, confusion, and falls.
=== SCIRI === The organization was formed in Iran in 1982 as the military wing of the Supreme Council for Islamic Revolution in Iraq. It was based in Iran for two decades during the rule of Saddam Hussein and led by Iranian officers. It consisted of several thousand Iraqi exiles, refugees, and Iraqi Army defectors who fought alongside Iranian troops in the Iran–Iraq War. The group was armed and directed by Iran. They briefly returned to Iraq in 1991 during the 1991 Iraqi uprising to fight against the government of Saddam Hussein, focusing on the Shia holy cities of Najaf and Karbala. They retreated into Iran after the uprising was brutally crushed by the Ba'athist regime. In 1995, during the Iraqi Kurdish Civil War, Iran deployed 5,000 Badr fighters to Iraqi Kurdistan to support the PUK forces.
In order to appeal to as many demographic groups as possible and better compete with its competitor, Wendy's, Burger King added a multi-tiered value menu in 1993 with items priced at 99¢, US$1.99 and $2.99. The additions, part of the CEO James Adamson's back-to-basics program called Operation Phoenix, were an attempt to add not only a value menu, but also a line of value meals. The tiered menu was replaced with a more standard value menu in 1998 while the value meals were separated into their own menu segment. This value menu featured seven products: Whopper Jr., five-piece Chicken Tenders, a bacon cheeseburger, medium-sized French fries, medium soft drink, medium onion rings, and a small milkshake. In 2002 and 2006, BK revamped its value menu, adding and removing several different products such as chili and its Rodeo Cheeseburger. Many of these items have since been discontinued, modified or relegated to a regional menu option. To better appeal to a more adult palate and demographic, BK introduced several new products to its menu in 2003, including several new or revamped chicken products, a new salad line and its BK Joe brand of coffee. Some of the new products, including their Enormous Omelet Sandwich line and the BK Stacker line, brought negative attention due to the large portion size, and amounts of unhealthy fats and trans-fats. Many of these products featured higher quality ingredients like whole chicken breast, Angus beef, and natural cheeses such as cheddar and pepper jack. Again, not all these products, such as the BK Baguette line, have met sales expectations.
== Prognosis == Symptoms of fibromyalgia are regarded as persistent in nearly all patients. The German Federal Ministry of Health guidance on FM refers to a longitudinal study (n = 1555) in which 10% of patients had substantial improvement in pain, 15% had moderate improvement, and 39% worsened. FM severity worsened in 36%. No average meaningful change in symptoms was found, and high levels of self-reported symptoms and distress continued for most patients. Fibromyalgia can cause substantial disability, with impacts on the ability to work, engage in recreational activities, and do household duties. Amongst people with fibromyalgia, the proportion that are able to maintain their jobs has been estimated at between 34% and 77%, and some research suggest the typical reduction in work hours is between 50-70%. There is variation in the level of impact, with 71.4% of those who are mild remaining in employment, compared to 61.2% of those who are moderate and 28.5% of those who are severe. Levels of pain can vary significantly over time, from severe pain to almost symptom-free phases. A 2023 meta-analysis found that FM people were at a standardized mortality ratio (i.e., observed mortality rates in the study population, compared to expected levels based on a standard population) of 3.37 (95% CI 1.52 to 7.50) for mortality due to suicide.
Sources: en.wikipedia.org
"The Sārnāth column may be interpreted, therefore, not only as a glorification of the Buddha's preaching symbolised by the crowning wheel, but also through the cosmological implications of the whole pillar as a symbol of the universal extension of the power of the Buddha's Law as typified by the sun that dominates all space and all time, and simultaneously an emblem of the universal extension of Mauryan imperialism through the Dharma. The whole structure is then a translation of age-old Indian and Asiatic cosmology into artistic terms of essentially foreign origin and dedicated, like all Asoka's monuments, to the glory of Buddhism and the royal house." The largest surviving group of free-standing stone dharmachakras was made much later and far to the east. Eng Jin Ooi and Peter Skilling count at least forty from the Dvaravati culture of present-day Thailand, about twelve of them inscribed, coming mainly from Lopburi, Suphan Buri, Chai Nat, Nakhon Pathom, Ratchaburi, Phetchaburi and Nakhon Sawan. Bands of pearls frame the felloe on either face; between the bands the felloe is usually flat and filled with pattern, and the outer edge carries a design Robert Brown called "foliage growth". The spokes take a form of Greek ionic capital, with three rings before the column and the middle ring banded with pearls. A wheel of this kind stood on an octagonal pillar set on a circular brick base, held by a stone bracket, with lions below it and a deer nearby.
Despite initial successes, however, Gericke realized that the time was not yet ripe for the general technical application and commercial use of hydroponics for producing crops. He also wanted to make sure all aspects of hydroponic cultivation were researched and tested before making any of the specifics available to the public. Reports of Gericke's work and his claims that hydroponics would revolutionize plant agriculture prompted a huge number of requests for further information. Gericke had been denied use of the university's greenhouses for his experiments due to the administration's skepticism, and when the university tried to compel him to release his preliminary nutrient recipes developed at home, he requested greenhouse space and time to improve them using appropriate research facilities. While he was eventually provided greenhouse space, the university assigned Hoagland and Arnon to re-evaluate Gericke's claims and show his formula held no benefit over soil grown plant yields, a view held by Hoagland. Because of these irreconcilable conflicts, Gericke left his academic position in 1937 in a climate that was politically unfavorable and continued his research independently in his greenhouse. In 1940, Gericke, whose work is considered to be the basis for all forms of hydroponic growing, published the book, Complete Guide to Soilless Gardening. Therein, for the first time, he published his basic formulas involving the macro- and micronutrient salts for hydroponically grown plants.
In October 1962 the weekly news magazine Der Spiegel published an analysis of the West German military defence. The conclusion was that there were several weaknesses in the system. Ten days after publication, the offices of Der Spiegel in Hamburg were raided by the police and quantities of documents were seized. Chancellor Adenauer proclaimed in the Bundestag that the article was tantamount to high treason and that the authors would be prosecuted. The editor/owner of the magazine, Rudolf Augstein spent some time in jail before the public outcry over the breaking of laws on freedom of the press became too loud to be ignored. The FDP members of Adenauer's cabinet resigned from the government, demanding the resignation of Franz Josef Strauss, Defence Minister, who had decidedly overstepped his competence during the crisis. Adenauer was still wounded by his brief run for president, and this episode damaged his reputation even further. He announced that he would step down in the fall of 1963. His successor was to be Ludwig Erhard. In the early 1960s, the rate of economic growth slowed down significantly. In 1962, the growth rate was 4.7%, and the following year it was 2.0%. After a brief recovery, the growth rate slowed again into a recession, with no growth in 1967. A new coalition was formed to deal with this problem. Erhard stepped down in 1966 and was succeeded by Kurt Georg Kiesinger. He led a grand coalition between West Germany's two largest parties, the CDU/CSU and the Social Democratic Party (SPD).
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.